 |
 |
 |
|
Archive 2004
VIOXX® Withdrawal and Impact on COX-2 Inhibitor Market
Summary of Quebec Ministry of Health
Impact of the "Weather Bomb" on prescription drug sales in Eastern Canada
Formulary Updates 2004
Posted December 23, 2004:
BritishColumbia
Newsletter effective January 21, 2005
Highlights
New Benefits added to LCA ir RDP Drug Lists: Requires Special Authorization: Apo-Alendronate 10mg Tab, Apo-Cyproterone 50mg Tab, Apo--Meloxicam 7.5mg, 15mg Tabs, Gen-Gabapentin 100mg, 300mg, 400mg Tabs SA Plan G only, Novo-Zopiclone 5mg, 7.5mg Tabs, Ratio-Carvedilol 3.125mg, 6.25mg, 12.5mg, 25mg Tabs,
No Special Authorization Required: Apo-Dexamethasone 4mg Tab, Apo-Tryptophan 500mg Cap, Novo-Ofloxacin 300mg, 400mg Tabs, PMS-Simvastatin 5mg, 10mg, 20mg, 40mg, 80mg Tabs, Rhoxal-Mirtazapine 30mg Tab, Sab-Anuzinc HC Plus Oint, Lin-Fosinopril 10mg, 20mg Tabs;
New LCA price changes: see newsletter for details;
New Benefits: Rhoxal-Mirtazapine 15mg Tab,
Non-Benefit: Apo-Alendronate 5mg Tab;
New LCA Categories: Amcinonide Oint 0.1%, Amcinonide Lot 0.1%, Carbidopal/Levodopa 50mg/200mg, Hydroxychloroquine 200mg Tab, Metoprolol Tartate 25mg Tab, Ofloxacin Opht Sol USP 0.3% (requires SA), Ranitidine HCL O/S 15mg/mL, Ofloxacin 200mg Tab, Trifluridine Drops 0.1%, Amiloride HCl 5mg Tab
Posted December 14, 2004:
Manitoba
Bulletin 46, effective January 3, 2005
Highlights
Additions Part 1: Apo-Amiloride 5mg Tab, Apo-Atenidone, 50mg/25mg/ 100mg/25mg Tabs, Apo-Bisoprolol 5mg, 10mg Tabs, Apo-Clonidine 0.025mg Tab, Apo-Quinine 200mg, 300mg Caps, Co Atenolol 50mg, 100mg Tabs, Co Fluvoxamine 50mg, 100mg Tabs, Co Lovastatin 20mg, 40mg Tabs, Co Metformin 500mg, 850mg Tabs, Gen-Clindamycin 150mg, 300mg Caps, Gen-Diltiazem CD 120mg, 180mg, 240mg, 300mg CD Caps, Gen-Mirtazapine 30mg Tab, Novo-Dipam 2mg, 5mg, 10mg Tabs, Novo-Mirtazapine 30mg Tab, Novo-Pramine 10mg, 25mg, 50mg Tabs, Novo-Triptyn 10mg, 25mg, 50mg Tabs, Octreotide Acetate Omega 50mcg/mL, 100mcg/mL, 200mcg/mL, 500mcg/mL Inj, Plan B 0.75mg Tab, pms-Amitriptyline 10mg, 25mg, 50mg Tab, pms-Diazepam 2mg,5mg, 10mg Tabs, pms-Furosemide 30mg, 40mg Tabs, pms-Hydrochlorothiazide 25mg, 50mg Tabs, Phoxal-acebutolol 100mg, 200mg, 400mg Tabs, Rhoxal-gliclazide 80mg Tab, Rhoxal-paroxetine 10mg, 20mg, 30mg Tabs, Rhoxal-sotalol 80mg, 160mg Tabs, Rhoxal-zopiclone 5mg, 7.5mg Tabs, Sab-Trifluridine 1% Opht Sol;
Additions Part 2: Apo-Methylphenidate 10mg, 20mg Tabs, Co Etidronate 200mg Tab, pms-Ofloxacin 0.3% Opht Sol;
Part 3 Additions: Alphagan P 0.15% Opht Sol, Apo-Leflunomide 10mg, 20mg Tabs, Co Meloxicam 7.5mg, 15mg Tabs, Gen-Meloxicam 7.5mg, 15mg Tabs, Novo-Meloxicam 7.5mg, 15mg Tabs, Rhoxal-anagrelide 0.5mg Cap, Rhoxal-Ioperamide 2mg Tab, Serc 24mg Tab;
New Interchangeable Categories and Products: see bulletin for details;
Product and Category Deletions: see bulletin for details;
Interchangeable Product Price Changes: see bulletin for details;
Discontinued Products (next formulary udpate): Allernix, Allernix Extra Strength, Alti-Acyclovir, Alti-Bromazepam, Alti-Cyclobenzaprine, Alti-Diltiazem, Alti-Doxepin, Alti-Prazosin, Asmavent, Atrovent(CFC), Betaderm, Chlorpromanyl, Cortoderm, Deproic, Diclotec, Diovan, Docusate Sodium, Effexor, Fluoderm, Gemfibrozil, Macrodantin, Motilidone, Nadostine, Neotopic, Novo-Chlorpromazine, Novo-Clopamine, Novo-Desipramine, Novo-Diltiazem SR, Novo-Dipiradol, Novo-Maprotiline, Novo-Meprazine, Novo-Salmol, Novo-Tenoxicam, Novo-Tripramine, Novo-Veramil, Nyaderm, Orafen, Peptol, Pilocarpine Hydrochloride, ratio-Desipramine, Renagel, Rubion, Salofalk, Serc, Sotamol, Stieva-A, Surmontil, Synflex, Synflex DS, Taro-Sone, Thiotepa, Thio Tepa, Triaderm, Ultradol, Viaderm KC;
Posted December 10, 2004:
Ontario
Update E2 effective December 21, 2004
Highlights
New Multi-Source Products: Co-Metformin 500mg Tab, Novo-Mirtazapine 30mg Tab, Novo-Ranidine 15mg/mL Oral Sol, PMS-Salbutamol 0.4mg/mL O/L, Taro-Fluconazole 50mg and 100mg Tabs
Posted December 3, 2004:
BritishColumbia
Formulary December 2004
Highlights
New version available.
Posted December 3, 2004:
NovaScotia
Bulletin December 1, 2004
Highlights
Change to Maximum Allowable Cost: Paroxetine 20mg, 30mg Tabs, Salbutamol 100mcg/dose Oral Inh;
Diabetic Test Strips Listed (were removed in error): Sof-Tact Test Strips 50, 100;
New Products Added: Novo-Dipam 2mg, 5mg, 10mg Tabs, Novo-Pramine 10mg, 25mg, 50mg Tabs, Novo-Triptyn 10mg, 25mg, 50mg Tabs;
New Interchangeable Products Added: Atenolol 50mg, 100mg Tab, Fluvoxamine 50mg, 100mg Tab, Meloxicam 7.5mg, 15mg Tab, Mirtazapine 30mg Tab;
New Inerchangeable Categories Added: Amiloride, Leflunomide, Ranitidine
Posted December 3, 2004:
Alberta
Additions to Alberta H&W effective December 1, 2004
Highlights
New Interchangeable Special Authorization Product: Apo-Leflunomide 10mg, 20mg Tabs
Posted November 29, 2004:
NewBrunswick
Bulletin effective November 29, 2004
Highlights
Benefit Additions: Atrovent HFA 20mcg Inh, Ultrase MS4 Cap, Ultrase MT20 Cap, Ultrase MT12 Cap, Nutropin 10mg Vial, Risperdal M 0.5mg and 1mg Tabs;
Special Authorization Additions: Lumigan 0.03% Oph Sol, Ezetrol 10mg Tab, Estradiol-17B 25mcg Trans Sys, Risperdal M 0.5mg, 1mg, 2mg Tabs;
Not Listed: Cipro XL 500mg Tab, Minirin 0.1mg Tab, Elidel 1% Crm, Ketek 400mg Tab
Posted November 26, 2004:
Quebec
Update effective November 24, 2004
Highlights
Modified Legend for the Formulary, Anti-tobacco treatment limitations, Phenylbutazone utilization will be limited to cases where other non-steroidal anti-inflammatories are not appropriate.
Posted November 19, 2004:
Alberta
Update effective November 9, 2004
Highlights
Products Delisted: ratio-Ectosone Mild 0.05% and Regular 0.1% topical cream, ratio-Oxycocet Tabs, ratio-Prednisolone 1% Opht Susp, ratio-Tecnal Cap and Tab, ratio Tecnal C1/4 and C1/2 Caps, ratio-Nystatin 500,000 Unit Tab
Posted November 15, 2004:
Ontario
Update E1 effective November 16, 2004
Highlights
New Interchangeable Products: Apo-Bisoprolol 5mg, 10mg Tabs with Monocor, Apo-Leflunomide 10mg, 20mg Tabs with Arava, novo-Meloxicam 7.5mg, 15mg Tabs with Mobicox, Rhoxal-Paroxetine 20mg, 30mg Tabs with Paxil
Posted November 12, 2004:
NovaScotia
October 2004 Bulletin effective November 1, 2004
Highlights
New Exception Status Drug: Pegasys RBV 180mcg/mL Inj / 200mg Tab and 180mcg/0.5mL Inj / 200mg Tab;
Not Listed: Viread 300mg Tab;
Updated Nurse Practitioners Prescribing List;
Posted November 1, 2004:
NovaScotia
October 2004 Bulletin effective November 1, 2004
Highlights
Exception Criteria Changes for Tamiflu; New Exception Drug (changed from Full Benefit Status): Serc 24mg Tab; Delisted Products: Vioxx 12.5mg/5mL Orl Susp, 12.5mg, 25mg Tabs, ratio-Heracline O/L;
New Full Benefit Listings: Atrovent HFA 20mcg/act Inh, Eligard 7.5mg, 22.5mg, 30mg Inj Kit, MetroLotion 0.75% Lot, Phoxal-Mirtazapine 15mg Tab, Mavik 4mg Cap, Lescol XL 80mg Tab;
New Exception Drug Status Drugs: Aerochamber Max Adult, Adult with Mask, Infant with Mask and Pediatric with Mask; Cipro XL 1,000mg Tab, Novo-Ofloxacin 200mg Tab, Zyperxa Zydis 15mg Tab;
Not Insured: Mavik 0.5mg Cap, Preterax 2/0.625mg Tab, Synthroid 0.127mg Tab;
Discontinued Products: Adrenalin 1:1000 Inj, Ana-Kit, Atropine Sulfate, Bacteriostatic Sod Chlor, Betagan, Cardizem SR, Cefuroxime, Corgard, Effexor, Eldepryl, Furosemide, Inflamase Forte, Lin-Megestrol, Macrodantin, Megace, Meperidine HCI, Mysoline, Noroxin, Novo-Diltazem SR, Novo-Methacin, ratio-Azathioprine, ratio-Doxazosin, ratio-Haloperidol, ratio-Levodopa/Carbidopa, ratio-Naproxen, ratio-Orciprenaline, ratio-Timolol Maleate, Rebetron Multidose Pen, Rovamycine, Salofalk, Serc, Stadol NS Nasal Sp, Stemetil,Stieva-A, Surmontil, T-Stat 2% Pads, Timpilo, Ultradol, Urecholine, Vitamin K1, B12, One-Touch Test Strips (25), One-Touch Fast Take Test Strips (25), One-Touch Regular Lancets (200), One-Touch SureStep Test Strips (100), Sof-Tact Test Strips (50), Sof-Tact Test Strips (100), Soft Clix Select lancets (100), Soft Clix Select lancets (200)
Posted November 1, 2004:
BritishColumbia
New Formulary Version
Posted October 26, 2004:
BritishColumbia
PharmaCare Newsletter, October 25, 2004
Highlights
Vioxx withdrawn from the market. New LCA Program Benefit
(Plans B, C, F, I and G): Clozapine 25mg, 100mg Tabs
Posted October 13, 2004:
NewBrunswick
Bulletin effective September 30, 2004
Highlights
Delisted: Vioxx
Posted October 12, 2004:
Ontario
ODB Update E - effective November 4, 2004
Highlights
New Limited Use Products: Alphagan P 0.15% Ophth Sol, Combigan 0.2%, 0.5% Ophth Sol 5mL Pk, Xalacom 50mcg/mL and 5mg/mL 0phth Sol 2.5mL Pk; New Products: Atrovent HFA 20mcg/Met Dose Inh, Reyataz 150mg, 200mg Cap;
Limited Use Changes: Alphagan 0.2% Ophth Sol, Azopt 1% Ophth Susp, Cosopt 2%, 0.5% OphthSol, Humalog 100U/mL Inj Sol 10mL Pk, 5x1mL Pk, 5x3mL Pk, Humalog Mix25 25%, 75% Inj Susp 3mL Pk, Lumigan 0.03% Ophth Sol 2.5mL Pk, NovoRapid 100U/mL Inj Sol 10mL pk, 5x3mL Pk, Ratko-Brimonidine 0.2% Ophth Sol, SereVent 25mcg/Met Dose Inh, SerVent Diskhaler Disks 50mcg/Blister, SereVent Diskus 50mcg Pd Inh, Travatan 0.004% Oph Sol 2.5mL Pk, Trusopt 2% Ophth Sol, Urso DS 500mg Tab, Xalatan 0.005% Oph Sol 2.5mL Pk
Posted October 12, 2004:
NIHB
Fall 2004 Updates
Highlights
Additions - All Provinces: Effective July 1, 2004: Apo-Clozapine 100mg Tab, Dom-Hydrochlorothiazide 25mg, 50mg Tab, Nu-Furosemide 20mg, 40mg Tab, Nu-Hydro 25mg, 50mg Tab;
Effective August 1, 2004: Apo-Amiloride 5mg Tab, Apo-Clozapine 25mg Tab, Apo-Cyproterone 50mg Tab, Dom-Amitriptyline 10mg, 25mg, 50mg Tab, Dom-Ciprofloxacin 250mg, 500mg, 750mg Tab, Dom-Clobazam 10mg Tab, Dom-Pravastatin 10mg, 20mg, 40mg Tab, Gabapentin 300mg, 400mg Cap, Gen-Hydroxychloroquine 200mg Tab, Novo-Citalopram 20mg, 40mg Tab, Nu-Azathioprine 50mg Tab, Nu-Citalopram 20mg, 40mg Tab, Nu-Feno-Micro 200mg Cap, Nu-Paroxetine 10mg, 20mg, 30mg Tab, Nu-Propafenone 150mg Tab, Nu-Simvastatin 5mg, 10mg, 20mg, 40mg, 80mg Tab, Nu-Terbinafine 250mg Tab, Nu-Verap SR 240mg Tab, Octreotide Acetate Omega 50mcg/mL, 100mcg/mL, 200mcg/mL, 500mcg/mL Inj, PMS-Simvastatin 5mg, 10mg, 20mg, 40mg, 80mg Tab, Pe-Ciprofloxacin 250mg, 500mg, 750mg Tab, Ratio-Amcinonide 0.1% Lot, Ratio-Amcinonide 0.1% Oint, Ratio-Citalopram 20mg, 40mg Tab, Ratio-Fenofibrate 200mg Cap, Timolol Maleate 0.25%, 0.5% Ophth Sol;
Effective September 1, 2004: Apo-Omeprazole 20mg Cap, Atrovent HFA 20mcg Inh, Novo-Ranitidine 15mg/mL Orl Sol, PMS-Metoprolol-L 25mg Tab, Proctol Suppository;
Posted October 8, 2004:
Quebec
Update October 2004
Highlights
Products Added: Apo-Omeprazole, Lescol XL plus many new generics (see bulletin for details); Price Changes (see bulletin for list);
Special Authority Additions: Aldara, Diane-35, Enbrel, Viread;
Modifications to Existing Special Authority: Cancidas, Cytovene, Ezetrol, Neupogen, Valcyte;
Declined: Avandament, Zavesca, Adderall XR, Neulasta, Pennsaid, Remeron RD
Posted October 8, 2004:
NewBrunswick
Bulletin effective October 7, 2004
Highlights
Regular Benefit Additions: Palladone IR 2mg, 4mg, 8mg Tabs, Palladone XL 12mg, 16mg, 24mg SRC, ratio-Methylphenidate 5mg Tab, Quinine Sulfate 300mg Tab;
Special Authorization Additions: Arimidex 1mg Tab, Aromasin 25mg Tab, Femara 2.5mg Tab, Rilutek 50mg Tab; Lovenex HP 150mg/mL, 120mg/0.8mL Syr, Urso DS 500mg Tab, Diovan 80mg, 160mg Tab,
Drugs Not Listed: Premplus, Arixtra, Avandamet, Bextra, Zometa
Posted October 6, 2004:
Ontario
Update D3 effective October 14, 2004
Highlights
New Multi-Source products: Apo-Dexamethasone 4mg Tab, Clasteon 400mg Cap, Co-Atenolol 50mg, 100mg Tabs, Co-Fluvoxamine 50mg, 100mg Tabs, Gen-Clindamycin 150mg, 300mg Caps, Triamcinolone Acetonide 40mg/mL, 50mg/5mL 200mg/5mL Inj Susp
Posted October 4, 2004:
BritishColumbia
October 2004 Update
Highlights
New version.
Posted October 4, 2004:
Saskatchewan
Bulletin - October 2004
Highlights
New Full Listing: Combigan 0.2%/0.5% Opht Sol, MetroLotion 0.75% Top Lot, Precision PCx Test Strip, Epinephrine 1mg/mL Inj Sol; Restriction (8 strips/year) Removed: Precision Extra Ketone;
New Exception Status Drugs: Axert 6.25mg, 12.5mg Tabs, Reyataz 150mg, 200mg Caps, CiproXL 1000mg Tab, CellCept 200mg/mL Orl Susp, Climara 25 and 75 25ug, 75ug Trans System, Vigamox 0.5% Opht Sol, Aldara 5% Top Crm, Fuzeon 108mg/vial Pwd for Sol, Ketek 400mg Tab,
New Full Formulary Interchangeable Lists: pms-Metoprolol-L, ratio-Fenofibrate MC, Nu-Medroxy, ratio-Amcinonide, ratio-Citalopram, pms-Simvastatin, Atrovent HFA, pms-Furosemide, Mirtazapine, Dom-Metoprolol-L, pms-hydrochlorothiazide, pms-Diazepam, Novo-Ranidine, Apo-Quinine, Apo-Amiloride, Apo-Chloral Hydrate Syrup, Apo-Atenidone, Prem-Paroxetine;
New Exception Drug Status Interchangeable List: Apo-Cyproterone, ratio-Carvedilol, Nu-Ciprofloxacin, CO Meloxicam, Apo-Alendronate, pms-Ofloxacin;
Revised Exception Status Drug Status: Prograf 0.5mg, 1mg, 5mg Cap, Ampoule 5mg/mL; Not Recommended: Lescol XL 80mg ER Tab, Humatrope 24mg Ca, Proctofoam-HC 1%/1% Rec Aer Foam, Preg Vit, Remeron RD 15mg, 20mg, 45mg Tabs, Evra 6.0mg/.60mg Trans System; Under Review: Gen-Clozapine, Apo-Clozapine, PegetronRedipen, Pegasys, Pegasys RBV, Apo-Cyclosporine, Rhoxal-Cyclosporine, Zavesca, Ciprodex, BenzaClin, Remodulin, Zyprexa IM; Note: Atrovent HFA will be interchangeable with Atrovent.
Posted September 28, 2004:
NovaScotia
September 2004 Bulletin
Highlights
New Product Listings effective October 1, 2004: Disulfiram 250mg Cap, Magic Mouthwash, BD Lancets 33g (100);
Change to MAC List for Fosinopril 10mg, 20mg Tabs, Hydroxyurea 10mg Cap, Lisinopril 5mg, 10mg, 20mg Tabs, Prednisolone Sodium Phosphate 1mg/mL 0/L
Posted September 27, 2004:
BritishColumbia
Newsletter, September 24, 2004
Highlights
Changes to LCA/RDP effective July 12, 2004: Apo-Azathioprine 50mg Tab, Gen-Azathioprine 50mg Tab, Ratio-Azathioprine 50mg Tab, PMS-Selegiline 5mg Tab, Quibron T SR 300mg Tab, Apo-Lithium Caronte 150mg, 300mg Caps;
New Drugs Categorized to LCA and/or RDP: Novo-Simvastatin 5mg, 10mg, 20mg, 40mg, 80mg Tabs;
New Benefits: Apo-Clozapine 25mg, 100mg Tabs, Atrovent HFA 20mcg Metered Dose Aerosol;
New Special Authorization Benefits: Climara 25 and Climara 7 Transdermal Systems;
Not Recommended for Coverage: Spiriva 18mcg Cap, Preterax 2mg/0.625mg Tab;
Drugs Under Review: Replagal, Fabrazyme, Xatral, Axert, Kineret, Serc, Botox, Alphagan, Combigan, Gynazole, Cipro XL, Ciprodex, DDAVP, Aricept, Metrolotion, Zavesca, Adderall XR, Vigamox, Evra, Zyprexa, Zyprexa Zydis, Tamiflu, Trileptal, Pegasys, Pegetron, Pegasys RBV, Coversyl, Elidel, Periostat, Teveten Plus, Enbrel, Proscar, Lescol XL, Reminyl, Aldara, Avonex, Rebif, Avapro, Venofer, Xalacom 50, Keppra, Cozaar, Metadol, Concerta, Actos, Actonel, Risperdal M-Tab, Exelon, Vioxx, Avandia, Humatrope, Ketek, Protopic, Forteo, Androderm, Mavik, Remodulin, Urso, Diaplex
Posted September 22, 2004:
Alberta
Alberta HR & E - Quarterly Updates effective October 1, 2004
Highlights
New Restricted Benefit: Robitussin Pediatric Cough and Cold Orl Liq;
Discontinued Products: MCT Oil Orl Liq, Subdue Orl Liq;
New Special Authorization Product: Ivanz 1g/vial Inj, Apo-Alendronate 10mg Tab, Apo-Cyproterone 50mg Tab;
Changes to Special Authorization Criteria: Enbrel 25mg/vial Inj, Pegetron 50mcg, 80mcg, 100mcg, 120mcg, 150mcg Injs per 200 mg Cap
Posted September 22, 2004:
Alberta
Alberta H & W - Quarterly Updates effective October 1, 2004
Highlights
Product Additions: Apo-Dexamethasone 4mg Tab, Atrovent HFA 20mcg/dose Metered Dose Aerosol, Biaxin 50 mg/ml Oral Susp, Clasteon 400mg Cap, Climara 25 1mg/pth Trans Pth, Colistimethate for Injection 150mg/vial, Desferrioxamine Mesilate 2g/vial Inj., Gen-Hydroxychloroquine 200mg Tab, Lescol XL 80mg ER Tab, Lin-Fosinopril 10mg, 20mg Tabs, Metrolotion 0.75% Top Lot, Novo-Simvastatin 5mg, 10mg, 20mg, 40mg, 80mg Tabs, PMS-Metoprolol-L 25mg Tab, Proctol Rectal Suppository, Ratio-Amcinonide 0.1% Top Crm, Ratio-Carvedilol 3.125mg, 6.25mg, 12.5mg, 25mg Tabs, Ratio-Citalopram 40mg Tab, Ratio-Fenofibrate MC 200mg Cap, Ratio-Metformin Hydrochloride 850mg Tab, Rhoxal-Mirtazapine 30mg Tab, Sab-Anuzinc HC Oint, Sab-Anuzinc HC Plus Oint, Sab-Trifluridine 1% Opht Sol, Synthroid 0.137mg Tab; New Restricted Benefit: Singulair 4mg Gran; Deleted Products: 642 65mg Tab, Darvon-N 100mg Cap; New Special Authorization: Invanz 1g/vial Inj, Apo-Alendronate 10mg Tab, Apo-Cyproterone 50mg Tab; Changes to Special Authorization Criteria: Enbrel 25mg/vial Inj, Pegetron 50mcg, 80mcg, 100mcg, 120mcg Inj per 200mg Caps.
Posted September 10, 2004:
Manitoba
Formulary - New Version
Posted September 10, 2004:
BritishColumbia
Formulary - New Version
Posted September 7, 2004:
Ontario
ODB Update D2 - effective September 14, 2004
Highlights
New Multi-Source Drugs: Apo-Atenidone 25mg/50mg (interchangeable with Tenoretic 50/25), 25mg/100mg (interchangeable with Tenoretic 100/25) Tabs, Co-Lovastatin 20mg, 40mg Tabs (interchangeable with Mevacor), Co Meloxicam 7.5mg, 15mg Tabs (interchangeable with Mobicox), Gen-Diltiazem CD 120mg, 180mg, 240mg, 300mg LA Caps (interchangeable with Cardizem CD), Gen-Meloxicam 7.5mg, 15mg (interchangeable with Mobicox), 30mg (interchangeable with Remeron) Tabs.
Posted September 3, 2004:
Manitoba
Bulletin 44 Revision effective November 1, 2004
Highlights
Effective November 1, 2004: Implementation of the Cox-2 benefit coverage move from Part 2 to Part 3, outlined in Bulletin 44, is delayed. Impacted products: Apo-Meloxicam, Celebrex, Mobicox, pms-Meloxicam, ratio-Meloxicam, Vioxx
Posted September 1, 2004:
Manitoba
Bulletin 45 effective September 1, 2004
Highlights
Part 1 Addition: Apo-Azathioprine 50mg Tab;
Part 3 Addition: Actos 15mg, 30mg, 45mg Tabs;
Discontinued Products: Atropine Sulfate, Dexamethasone Sodium Phosphate, Erythromycin, Gentamicin Sulfate, Inflasmase Forte, Levobunolol Hydrochloride, Pilocarpine Hydrochloride, Prednisolone Sodium Phosphate Forte, Surmontil, Tobramycin, Tropicamide;
New Interchange Product: Apo-Azathioprine 50mg Tab,
Interchangeable Produce Price Changes: See bulletin for details;
Product Name Change: BD Lancets Microfine now known as BD Ultra Fine 33; Product DHE has been transferred to SteriMax Inc; Midamor and Moduret have been transferred to Orbus Pharma Inc.
Posted August 16, 2004:
NewBrunswick
MAP List August 2004
Posted August 11, 2004:
Ontario
Update D1, Ontario Drug Benefit Formulary/Comparative Drug Index, Summary of changes, No. 38, effective August 11, 2004
Highlights
New Multi-Source Drug(s)
DIN: 02249510 PRODUCT: Apo-Amiloride 5mg Tab (Interchangeable with Midamor)
MFR: APX DBP: 0.2002
DIN: 02239288 PRODUCT: Apo-Flunisolide 0.025% Nas Sp-25mL Pk (Interchangeable with Rhinalar)MFR: NXP DBP: 12.4740
DIN: 02245698 PRODUCT: Apo-Tobramycin 0.3% Oph Sol (Interchangeable with Tobrex) MFR: APX DBP: 1.0480
Posted August 9, 2004:
Ontario
ODB Bulletin
Highlights
New Multi-Source Drugs: Apo-Amiloride 5mg Tab, Apo-Flunisolide 0.025% Nas Ap-25 mL Pk, Apo-Tobramycin 0.3% Oph Sol
Posted August 9, 2004:
Manitoba
Bulletin 44 effective September 1, 2004
Highlights
Part 1 Additions: Apo-Cyproterone 50mg Tab, Apo-Dexamethasone 4mg Tab,
Atrovent HFA 0mg MDInh, Combigan 0.2%/0.5%mL Oph Sol, Dapsone 100mg Tab,
Gen-H7droxychloroquine 200mg Tab, Lescol XL 80mg ER Tab, Lin-Fosinopril 10mg,
20mg Tabs, MetroLotion 0.75% Top Lot, Novo-Citalopram 20mg, 40mg Tabs,
Novo-Ranidine 15mg/mL Orl Sol, Novo-Simvastatin 5mg, 10mg, 40mg,
80mg Tabs, Novo-Zopiclone 5mg, 7.5mg Tabs, pms-Metoprolol-L 25mg Tab,
pms-Simvastatin 5mg, 10mg, 20mg, 40mg, 80mg Tabs,
ratio-Amcinonide 0.1% Top Oint and Top Lot, ratio-Carvedilol 3.125mg, 6.25mg, 12.5mg, 25mg Tabs,
ratio-Citalopram 20mg, 40mg Tab, ratio-Fenofibrate MC 200mg Cap, Rhoxal-mirtazapine 15mg, 20mg Tabs,
Ascensia Microfill Gloucose Test Strips;
Part 1 Deletions: Apo-Naproxen EC 250mg, 375mg, 500mg Tabs EC Tabs;
Part 2 Additions: Apo-Alendronate 10mg Tab, Cipro XL 1000mg Tab, Eligar 30mg Inj, Humatrope 24mg Inj,
pms-Ciprofloxacin 250mg, 500mg, 750mg Tabs;
Part 2 Deletions: Apo-Meloxicam 7.5mg, 15mg Tab,
Celebrex 100mg, 200mg Caps, Mobicox 7.5mg, 15mg Tabs, pms-Meloxicam 7.5mg, 15mg Tabs,
ratio-Meloxicam 7.5mg, 15mg Tabs, Vioxx 12.5mg, 25mg Tabs;
Part 3 Additions: Apo-Alendronate 5mg Tab, Apo-Meloxicam 7.5mg, 15mg Tabs,
Apo-Naproxen EC 250mg, 375mg, 500mg tabs, Bextra 10mg, 20mg Tabs, Ceftazidime 1g Inj,
Celebrex 100mg, 200mg Caps, Ceptaz 1g Inj, Fortaz 1g Inj, Mobicox 7.5mg, 15mg Tabs,
pms-Meloxicam 7.5mg, 15mg Tabs, ratio-meloxicam 7.5mg, 15mg Tabs, Vioxx 12.5mg, 25mg Tabs;
New Interchangeable Categories and New Interchangeable Products: see Bulletin; Product Deletions:
Apo-Ampi, Gentamicin Sulfate, Glucostix, Idarac, Surmontil;
Not Recommended Products: Apo-Clozapine 25mg, 100mg Tabs, Avandamet 1mg/500mg, 2mg/500mg, 4mg/500mg Tabs,
Cipro XL 500mg MR Tab, Palladone IR 2mg, 4mg, 8mg Tabs, Pennsaid 1.5% Top Sol, PregVit Tabs, Proctofoam HC 1%/1% Foam;
Interchangeable Price Changes: see Bulletin;
Discontinued Products and Manufacturer Updates: see Bulletin
August 9, 2004:
BritishColumbia
Electronic Version - August 2004
Posted August 3, 2004:
NIHB
Summer 2004 Updates
Highlights
Additions all provinces except Quebec effective March 1, 2004: Apo-Ciproflox 250, 500, 750mg Tabs, Apo-Citalopram 20, 40mg Tabs,
Apo-Paroxetine 10mg Tab, Co-Ciprofloxacin 250, 500, 750mg Tabs, Co-Citalopram 20, 40mg Tabs, Gen-Ciprofloxacin 250, 500, 750mg Tabs,
Gen-Paroxetine 10mg Tab, Novo-Ciprofloxacin 250, 500, 750mg Tabs, Novo-Paroxetine 10, 20, 30mg Tabs, PMS-Ciprofloxacin 250, 500, 750mg Tabs,
PM-Citalopram 20, 40mg Tabs, PMS-Paroxetine 10mg Tab, Ratio-Ciprofloxacin 250, 500, 750mg Tabs, Ratio-Paroxetine 10mg Tab, Rhoxal-Citlopram 20, 40mg Tabs;
Additions Effective April 1, 2004: Apo-Levocarb 200mg/50mg CR Tab, Apo-Metronidazole 500mg Cap, Apo-Ofloxacin 0.3% Opth Sol, Co-Pravastatin 10, 20, 40mg Tabs,
Co-Ranitidine 150, 300mg, Tabs, Dom-Citalopram 20, 40mg Tabs, Dom-Paroxetine 10, 20, 30mg Tabs, Novo-Lamotrigine 25, 100, 150mg Tabs, Novo-Ofloxacin 200, 300, 400mg Tabs,
Ratio-Lamotrigine 150mg Tab, Rhoxal-Ciprofloxacin 250, 500, 750mg Tabs, Sab-Opticort Opth Sol,
Additions Effective May 1, 2004: Apo-Dexamethasone 4mg Tab, Lin-Fosinopril 10, 20, 40mg Tabs, Lovastatin-20 20mg Tab, Lovastatin-40, 40mg Tab, Novo-Gabapetin 600mg Tab,
Novo-Simvastatin 5, 10, 20, 40, 80mg Tabs, Riva-Baclofen 10, 20mg Tabs, Riva-Fenofibrate Micro 200mg Cap, Riva-Simvastatin 5, 10, 20, 40, 80mg Tabs, Sab-Anuzinc HC 0.5%/0.5% Oint,
Simvastatin-10 10mg Tab, Simvastatin-20 20mg Tab, Simvastatin-40 40mg Tab; Addtions Quebec effective March 1, 2004: Apo-Ciproflox 250, 500, 750mg Tabs, Apo-Citalopram 20, 40mg Tabs,
Apo-Paroxetine 10mg Tab, Co-Ciprofloxacin 250, 500, 750mg Tabs, Co-Citalopram 20, 40mg Tabs, Gen-Ciprofloxacin 250, 500, 750mg Tabs, Gen-Paroxetine 10mg Tab, Novo-Ciprofloxacin 250, 500, 750mg Tabs,
Novo-Paroxetine 10, 20, 30mg Tabs, PMS-Ciprofloxacin 250, 500, 750mg Tabs, PMS-Citalopram 20, 40mg Tabs, PMS-Paroxetine 10mg Tab, Ratio-Ciprofloxacin 250, 500, 750mg Tbs,
Ratio-Paroxetine 10mg Tab, Rhoxal-Citalopram 20, 40mg Tabs;
Effective April 1, 2004: Apo-Levocarb 200mg/50mg CR Tab, Apo-Metronidazole 500mg Cap, Apo-Ofloxacin 0.3% Opth Sol, Co-Pravastatin 10, 20, 40mg Tabs, Co-Ranitidine 150, 300mg Tabs,
Dom-Citalopram 20, 40mg Tabs, Dom-Paroxetine 10, 20, 30mg Tabs, Novo-Lamotrigine 25, 100, 150mg Tabs, Novo-Ofloxacin 200, 300, 400mg Tabs, Ratio-Lamotrigine 150mg Tab,
Rhoxal-Ciprofloxacin Tab 250, 500, 750mg Tabs, Sab-Opticort Opth/Otic Sol; Effective May 1, 2004: Apo-Dexamethasone 4mg Tab, Lin-Fosinopril 10, 20mg Tabs, Lovastatin-20 20mg Tab,
Lovastatin-40 40mg Tab, Novo-Gabapentin 600mg Tab, Novo-Simvastatin 10, 20, 40, 80mg Tabs, Riva-Baclofen 10, 20mg Tabs, Riva-Fenofibrate Micro 200mg Cap, Riva-Simvastatin 5, 10, 20, 40, 80mg Tabs,
Sab-Anuzinc HC 0.5%/0.5% Oint, Simvastatin-10 10mg Tab, Simvastatin-20 20mg Tab, Simvastatin-40 40mg Tab; Limited Use Benefits Update effective April 1, 2004: Apo-Meloxicam 7.5, 15mg Tabs,
Ratio-Meloxicam 7.5, 15mg Tabs, Effective June 1, 2004: Enbrel 25mg/vial Pwd/Sol, Remicade 100mg/via Pwd/Sol
Posted July 27, 2004:
Newfoundland
July Interchangeable List
Highlights
See documentation.
Posted July 23, 2004:
NovaScotia
July Bulletin
Highlights
Note: Apo-Omeprazole 20mg Cap is NOT interchangeable with Losec 20mg Tab.
New Exception Status Drug: Apo-Omeprazole 20mg Cap; Not Listed:
Evra 0.6/6mg and 0.75/6mg Patch, Iressa 250mg Tab; Multi Discontinued Products and an updated Maximum Allowable Cost List effective August 1, 2004
Posted July 16, 2004:
Saskatchewan
Saskatchewan Formulary July 2004 - July 2005
Highlights
Electronic copy received.
Posted July 16, 2004:
NewBrunswick
MAP List July 2004
Posted July 12, 2004:
NewBrunswick
Bulletin effective July 2004
Highlights
Additions: Fosamax 5mg Tab, Apo-Alendronate 5mg, 10 g Tabs, ratio-Carvedilol 3.125mg, 6.25mg, 12.5mg, 25mg Tabs, Rtio Ciproflox 750mg Tab, ratio-Citalopram 20mg, 40mg Tabs, Apo-Clozapine 25mg, 100mg Tabs, Apo-Cyproterone 50mg Tab, Apo-Dexamethasone 4mg Tab, Diflucan, Fluconazole Omega 2mg/mL Liq IV, Gen-Hydroxychloroquine 200mg Tab, Sinemet CR, Apo-Levocarb CR 200mg/50mg Srt , pms-Meloxicam 7.5mg, 15mg Tabs, ratio-Metformin 850mg Tab, Rhoxal-Mirtazapine 30mg Tab, ratio-Mometasone 0.1% Ont Top, Novo-Ofloxacin 200mg, 300mg, 400mg Tabs, Dom-Paroxetine 10mg Tab, Novo-Simvastatin, Rhoxal-Simvastatin 5mg, 10mg, 20mg Tabs
Posted July 12, 2004:
Alberta
Alberta H&W and HR&E - Addition July 1, 2004
Highlights
New Restricted Benefit and Criteria for Special Authorization: Axert 6.25mg, 12.5mg Tabs
Posted July 8, 2004:
BritishColumbia
New Electronic Version
Posted July 6, 2004:
Saskatchewan
Saskatchewan Formulary July 2004 - July 2005
Highlights
Hard copy received.
Posted July 6, 2004:
Saskatchewan
Saskatchewan Bulletin July 2004
Highlights
New Full Benefit Listing: Mavik 0.5mg, 4mg Cap, Rhoxal-Mirtazapine 15mg Tab;
New Exception Status: Alphagan 0.15% Oph Sol, Spiriva 18ug/dose Pwd/Cap, Nexium 20mg,
40mg DR Tab, Apo-Omeprazole 10mg Cap; Change in Status from EDS to Full Benefit:
Didronel 200mg, Gen-Etidronate 200mg Tab; New Interchangeable Listings and Changes:
see bulletin for details; Not Recommended for Listing: Periostat 20mg Cap; Under Review:
Axert 6.25mg, 12.5mg Tab, Reyataz 150mg, 200mg Cap, Combigan 0.2%, 0.5% Oph Sol,
Gen-Clozapine 25mg, 100mg Tab, Apo-Clozapine 25mg, 100mg Tab,
Apo-Cyclosporine 100mg/mL Liq, Rhoxal-Cyclosporine 100mg Cap, Evra 6.0mg/0.6mg Trans Sys,
Zyprexa IM - 10mg Vial, Pegasys 180ug/0.5mL, 180ug/1mL Vial; Delisted Products:
Dom-Paroxetine 10mg Tab.
Posted July 5, 2004:
Alberta
Alberta Health & Wellness Quarterly Report July 2004
Highlights
New Products Added: Apo-Ciproflox, Co Ciprofloxacin, Gen-Ciprofloxacin, Novo-Ciprofloxacin,
PMS-Ciprofloxacin, Ratio-Ciprofloxacin, Rhoxal-Ciprofloxacin 250mg, 500mg,
750mg Tab; Dom-Paroxetine 10mg Tab; Apo-Calcitonin 200iu/dose metered nasal spray;
PMS-Mirtazapine 30mg Tab; New Special Special Authorization: Enbrel 25mg/vial
for Juvenile Rheumatoid Arthritis; Changes to Special Authorization Criteria:
Intron A, Roferon-A for treatment of chronic active hepatitis B and not hepatitis C;
Rebetron - removed for hepatitis C.
Posted June 30, 2004:
NovaScotia
June 2004 Bulletin effective July 1, 2004
Highlights
New Full Benefits: Hydrocortisone 0.5% and 1% in Dermabase,
Hydrocortisone 0.5% and 1% in Glaxal Base, Hydrocortisone 0.5% and 1% in Soft Petrolatum,
Coversyl 8mg Tab; New Exception Status Drugs: Aldara 5% Cr,
Axert 6.25mg, 12.5mg Tabs, Metadol 1mg, 5mg, 10mg, 25mg Tabs,
Methadone 0/L; Not Listed: Alphagan P 0.15% Oph Sol, Fuzeon 108mg/vial Inj,
Metadol 1mg/mL , 10mg/mL O/L, Reyataz 150mg, 200mg Caps;
New Interchangeable Products Added and New MAC price categories (see bulletin for details)
Posted June 29, 2004:
Ontario
Formulary Version 38, Update D, Summary of Product Changes, effective July 20, 2004
Highlights
Product Additions: Single Source Full Coverage:
3TC 300 mg Tab, Coversyl 8 mg Tab, Eligard 7.5 mg Inj Pd-Kit,
Eligard 22.5mg Inj Pd-Kit, Mavik 4 mg Cap,
Risperdal M-Tab (0.5, 1 and 2 mg) Orally Disintegrating Tabs,
Single Source Limited Use Coverage: Proscar 5 mg Tabs.
Multi-Source Full Coverage: Apo-Citalopram 20 mg and 40 mg Tabs,
Apo-Cyproterone 50 mg Tabs, Apo-Ketorolac 0.5% Oph Sol, Apo-Levocarb CR 200mg & 50mg Tab,
Apo-Meloxicam 7.5 mg Tabs, Apo-Meloxicam 15 mg Tabs, Apo-Metronidazole 500 mg Caps,
Co-Citalopram 20 mg and 40mg Tabs, Co-Ranitidine 150 mg and 300 mg Tabs,
Gen-Citalopram 20 mg 40 mg Tabs, Gen-Hydroxychloroquine 200 mg Tabs,
Lin-Fosinopril 10 mg Tabs, Lin-Fosinopril 20 mg, Novo-Citalopram 20 mg and 40 mg Tabs,
Novo-Simvastatin 5 mg 10 mg 20 mg 40 mg and 80 mg Tabs,
PMS-Citalopram 20 mg and 40 mg Tabs, PMS-Mirtazapine 30 mg Tabs, PMS-Mometasone 0.1% Oint,
PMS-Prednisolone 6.7mg/5mL O/L, PMS-Simvastatin 5 mg 10 mg 20 mg 40 mg and 80 mg Tabs,
Questran Light 4 g Pk Oral Pd-Pouch, Ratio-Amcinonide 0.1% Lot, Ratio-Amcinonide 0.1% Oint,
Ratio-Carvedilol 3.125mg 6.25mg 12.5mg Tab and 25mg Tabs, Ratio-Citalopram 20 mg and 40 mg Tabs,
Ratio-Fenofibrate MC 200 mg Caps, Ratio-Lamotrigine 150 mg Tab,
Ratio-Mometasone 0.1% Oint, Rhoxal-Citalopram 20 mg and 40 mg Tabs,
Rhoxal-Glyburide 2.5 mg and 5 mg Tabs, Rhoxal-Metoprolol(Type L) 50mg 100 mg Tabs,
Rhoxal-Mirtazapine 30 mg Tabs.
Multi-Source Limited Use Coverage: Apo-Alendronate 10 mg Tabs, Apo-Ciproflox 250 mg 500 mg and 750 mg Tabs,
Apo-Omeprazole 20 mg Caps, Co-Ciprofloxacin 250 mg 500 mg and 750 mg Tabs,
Gen-Ciprofloxacin 250 mg 500 mg and 750 mg Tabs, Novo-Ciprofloxacin 250 mg 500 mg and 750 mg Tabs,
PMS-Ciprofloxacin 250 mg 500 mg and 750 mg Tabs, Ratio-Ciprofloxacin 250 mg 500 mg and 750 mg Tabs,
Rhoxal-Ciprofloxacin 250 mg 500 mg and 750 mg Tabs,
For more details, click here to view update D of Formulary version 38.
Posted June 28, 2004:
Quebec
Update June 24, 2005
Highlights
Addition of Products: Avodart 0.5mg Cap, Axert 6.25mg, 12.5mg,
Reyatax 150mg, 200mg Caps; Declined: Periostat 20mg Cap, Evra 6mg/0.60mg,
Nicorette Inhaler 10mg, Paxil CR 12.5mg, 25mg, Remodulin 1.0mg/mL, Zyprexa 10mg;
Exception Status Drug Added: Alphagan 0.15%; Modifications to Criteria:
Fludara 10mg, Fuzeon 108mg, Plavix 75mg, Protopic 0.03%, 0.1%, Valcyte 450mg;
Changes to Dressings Listing (see bulletin for details)
Posted June 24, 2004:
NewBrunswick
MAP List June 2004
Highlights
Full Benefit Additions: Apo-Ranitidine, Novo-Ranidine, ratio-Ranitidine, Nu-Ranit,
Gen-Ranitidine, Zantac, Ranitidine (no longer requires special authorization), pms-Ranitidine,
Rhoxal-Ranitidine 150mg, 300mg Tabs; Crestor 10mg, 20mg, 40mg Tabs;
Special Authorization Additions: Apo-Omeprazole 20mg CAP; Spiriva 18mcg CAP for INH;
Revised Special Authorization Criteria: Fosamax 10mg, 70mg Tabs, Actonel 5mg and 3mg Tabs;
Drugs Reviewed and Not Listed: Fosamax 5mg Tab, Androderm 12.2mg, 24.3mg Transdermal, AndroGel 1% Gel,
Tarka 1/240mg, 2/180mg, 2/240mg, 4/240mg Tabs
Posted June 24, 2004:
NewBrunswick
Bulletin effective June 24, 2004
Highlights
Full Benefit Additions: Apo-Ranitidine, Novo-Ranidine, ratio-Ranitidine, Nu-Ranit,
Gen-Ranitidine, Zantac, Ranitidine (no longer requires special authorization), pms-Ranitidine,
Rhoxal-Ranitidine 150mg, 300mg Tabs; Crestor 10mg, 20mg, 40mg Tabs;
Special Authorization Additions: Apo-Omeprazole 20mg CAP; Spiriva 18mcg CAP for INH;
Revised Special Authorization Criteria: Fosamax 10mg, 70mg Tabs, Actonel 5mg and 3mg Tabs;
Drugs Reviewed and Not Listed: Fosamax 5mg Tab, Androderm 12.2mg, 24.3mg Transdermal, AndroGel 1% Gel,
Tarka 1/240mg, 2/180mg, 2/240mg, 4/240mg Tabs
Posted June 15, 2004:
Manitoba
Formulary/Interchangeable Lists
Highlights
June 2004 Formulary and June 15, 2004 Interchangeable List
Posted June 14, 2004:
BritishColumbia
PharmaCare Newsletter June 11, 2004
Highlights
New Benefits/LCA categories on Plans B, C, G, I, and G: Apo-Ciproflox,
C0-Ciprofloxacin, Gen-Ciprofloxacin, Novo-Ciproflosacin, Pms-Ciprofloxacin,
Ratio-Ciprofloxacin, Thoxal-Ciprofloxacin, Cipro 205 - 250mg, 500mg, 750mg Tabs,
New Special Authorization Benefit: Apo-Omeprazole, Losec 20mg Tabs;
New Benefits to LCA/RDP categories on Plans B, C, F, I and G:
Apo-Metronidazole 500mg Cap, Co Ranitidine 150mg, 300mg Tabs, Novo-Paroxetine 20mg,
30mg Tab, Ratio-Simvastatin 5mg, 10mg, 20mg, 40mg, 80mg Tabs, Rhoxal-Citalopram 20mg,
40mg Tabs, Rhoxal-Simvastatin 5mg, 10mg, 20mg, 40mg, 80mg Tabs;
Partial to Full Benefit LCA/RDF: SSD Crm 1%
Posted June 8, 2004:
Newfoundland
Benefit and Interchangeable Lists - Version June 8, 2004
Highlights
See documentation.
Posted June 4, 2004:
Alberta
Additions effective May 1, 2004
Highlights
New Special Authorization: Pegasys 180mcg/mL Inj and 180 mcg/syr Inj Syr
Posted May 17, 2004:
Manitoba
Bulletin 43 effective June 15, 2004
Highlights
Part I Additions: Accuretic 10mg/25mg Tabs, Apo-Citalopram 20mg, 40mg Tabs, Apo-Levocarb CR 200mg/50mg CR Tab, Co Citalopram 20mg, 40mg Tabs,
Co Pravastatin 10mg, 20mg, 40mg Tabs, Co Ranitidine 150mg, 300mg Tabs, Coversyl 8mg Tb, Gen-Citalopram 20mg, 40mg Tabs, Gen-Gabapentin 100mg, 300mg, 400mg Caps,
Methylprednisolone Acetate 40mg/mL, 40mg/mL wp, 80 mg/mL, 80mg/mL wp Inj, Novo-Fosinopril 10mg, 20mg Tabs, Novo-Lamotrigine 25mg, 100mg, 150mg Tabs,
Novo-Paroxetine 10mg, 20mg, 30mg Tabs, pms-Cigalopram 20mg, 40mg Tabs, pms-Mirtazapine 30mg Tab, pms-Mometasone 0.1% Top Oint, Preterax 2mg/0.625mg Tab,
ratio-Lamortrigine 150mg Tab, ratio-Meformin 850mg Tab, ratio-Mometasone 0.1% Top Oint, ratio-Simvastatin 5mg, 10mg, 20mg, 40mg, 80mg Tabs, Rhoxal-citalopram 20mg, 40mg Tabs,
Rhoxal-simvastatin 5mg, 10mg, 20mg, 40mg, 80mg Tabs, Risperdal M-Tab 0.5mg, 1mg, 2mg OD Tab, Sab-Opticort 5mg/0.05mg/0.5mg/mL Otic/Opth Sol, Supeudol 10mg, 20mg Supp,
Testosterone Cypionate 100mg/mL Inj, 3TC 300mg Tab, Zyprexa Zydis 15mg OD Tab;
Part 1 moves to Part II: HP-PAC 30mg/500mg/500mg Cap/Tab/Cap, Losec 1-2-3A 20mg/500mg/1000mg Tab/Tab/Cap,
Losec 1-2-3 M 20mg/250mg/500mg Tab/Tab/Tab; Part II Additions/Amendments: Apo-Ciproflox 250mg, 500mg, 750mg Tabs, Apo-Meloxicam 7.5mg, 15mg Tabs, Apo-Ofloxacin 0.3% Opth Sol, Apo-Omeprazole 20mg Cap,
Co Ciprofloxacin 250mg, 500mg, 750mg Tab, Eligard 7.5mg, 22.5mg Inj, Gen-Ciprofloxacin 250mg, 500mg, 750mg Tabs, Novo-Ciprofloxacin 250mg, 500mg, 750mg Tabs, Novo-Clavamoxin 875mg/125mg Tab,
pms-Meloxicam 7.5mg, 15mg Tab, ratio-Ciprofloxacin 2590mg, 500mg, 750mg Tabs, ratio-Meloxicam 7.5mg, 15mg Tabs, Rhoxal-ciprofloxacin 250mg, 500mg, 750mg Tabs;
Part II Additions: Apo-Trytophan 500mg Cap, Apo-Tryptophan 500mg, 1g Tabs, Keppra 250mg, 500mg, 750mg Tabs, Pegasys 180mcg/0.5mL, 180mcg/mL Syr & Vial;
Multiple New Interchangeable Categories and Products (see formulary); Deletions: Adrucil, Apo-Ibuprofen, Aristocort, Atropine, Celestoderm V/2, Cipro 100,
Clonapam, Cortate, Edecrin, Ludiomil, Motrin, MS Contin, Novolin ge Lente, Novolin ge Ultralente, Novo-Profen, Orudis SR, Pentasa, pms-Fluconazole, Procyclid,
Propanthel, Rovamycine, Surmontil, Vanceril, Vivelle, Voltaren, Wellferon; Price Changes (see formulary); Discontinued Products: Apo-Ampi, Gentamicin Sulfate,
Glucostix, Idarac, Surmontil; Manufacturer Updates (see formulary).
Posted May 11, 2004:
Nova Scotia
May Bulletin effective May 15, 2004
Highlights
New Products Added: Apo-Theo LA 100mg, 200mg, 300mg Tabs, Gen Teal 0.3% Oph Gel,
Remeron RD 15mg, 30mg, 45 mg Tabs; Exception Status Added: Humatrope 24mg/vial Inj;
Not Listed: 3TC 300mg Tab, PregVit Tab; Changes to Exception Criteria:
Gleevac, Detrol, Unidet, Ditropan XL; New MAC List Categories: Ciprofloxacin 250mg,
500mg, 750mg Tabs, Dexamethasone, Framycetin Sulfate & Gramicidin Oph/Otic Sol,
Fluconazole 2mg/mL Inj, Levodopa 200mg Tab, Carbidopa 50mg Tab, Vasopressin 20 units/mL USP Inj
Posted May 7, 2004:
NIHB
Version: April 2004
Highlights
Updated Benefit List and Limited Use Benefits and Criteria - see formulary for details.
Posted May 5, 2004:
NewBrunswick
Bulletin, April 30, 2004
Highlights
Benefit Additions: FXT40 40mg Cap, pms-Atenolol 25mg Tab;
Special Authorization Additions: Symbicort 100mcg/6mcg and 200mcg/6mcg metered does inhaler,
Duragesic 15mcg/hr, 50mcg/hr, 75mcg/hr, 100mcg/hr transdermal, Xalacom 50mcg/5mg/mL Opth Sol, Valcyte 450mg Tab,
Pegetron Inj + 200mg Cap, Actonel 35mg Tab, Rapamune 1mg Tab, Humatrope 1mg, 6mg, 12mg, 24mg Inj,
Saizen 3.33mg and 5mg Inj;
Drugs Not Listed: Kineret 100mg/0.67mL Inj, Clindoxyl 1%, 5% Top Gel,
Amaryl 1mg, 2mg, 4mg Tab, Zelnorm 6mg Tab
Posted May 5, 2004:
British Columbia
Drug Benefit List May 4, 2004
Highlights
See electronic copy.
Posted May 5, 2004:
Newfoundland
Drug Interchangeable Formulary May 4, 2004
Highlights
Drug Interchangeable Formulary Version May 4, 2004
Posted May 5, 2004:
Alberta
Alberta Health & Wellness Additions effective May 1, 2004
Highlights
New Interchangeable Products: Apo-Ciproflox, Co Ciprofloxacin, Gen-Ciprofloxacin, PMS-Ciprofloxacin, ratio-Ciprofloxacin, Rhoxal-Ciprofloxacin 250, 500, 750 mg Tabs. LCA Pricing for these products will be applied effective July 1, 2004.
New Special Authorization Product: Pegasys 180 mcg/mL Inj and Sry
Posted May 5, 2004:
Quebec
RAMQ Communique April 28, 2004
Highlights
Modification: K-Citra
Posted April 23, 2004:
Alberta
Alberta Health & Wellness Update April 23, 2004
Highlights
AH&W LCA price policy will not be applied to the Dimenhydrinate 50mg/mL Inj grouping; Updated Human Resources and Employment Days' Supply Guideline effective March 2004 - see bulletin for details.
Posted April 23, 2004:
Quebec
April 28, 2004 Update
Highlights
Benefit Additions: Invanz 1g Pd Inj, Ketek 400mg; Exceptions: AndroGel Gel Top 1%, Avelox 400mg/250mL IV, Ezetrol 10mg, Metadol 1, 5, 10, 25mg, Pegasys 180mcg/0.5mL and 180mcg/1mL Inj Sol, Zometa, IV 4mg, Concerta 18,36, 54mg
Posted April 23, 2004:
Nova Scotia
April 2004 Bulletin
Highlights
Changes to PIN Diabetc Supplies.
Effective August 1, 2004 the old PINs will not be allowed.
Status Change effective April 1, 2004: Desmopressin oral tablets,
nasal spray, and nasal drops are now Full Benefit Status, effective
July 1, 2004 they will be Exception Stutus benefits. Numerous
Discontinued Products and DIN Changes for Proctosedyl Oint and
Rythmodan 100 and 150mg Cap and Rythmodan-LA 250mg Tab.
Posted April 19, 2004:
NIHB
Spring 2004 Additions, Updates
Highlights
Additions Quebec effective Dec 1, 2003: Apo-Paroxetine and PMS-Paroxetine 20 and 30mg Tabs;
effective Jan 1, 2004: Gen-Etidronate 200mg Tab; effective Feb 1, 2004: Accuretic 20 and 25mg Tabs,
Advil Junior Strength 100mg Tab, Apo-Hydroxyurea 500mg Cap, Coversyl 8mg Tab, Dom-Furosemide 20 and 40mg Tab,
Gen-Citalopram 20 and 40mg Tab, Gen-Gabapentin 100, 300 and 400mg Cap, Novo-Clavamoxin 875 and 125mg Tab,
Novo-Fosinopril 10 and 20mg Tab, PMS-Divalproex 125, 250 and 500mg Tab, PMS-Mometasone 0.1% Oint,
Polyderm Oint, Proctol 5mg/5mg and 10mg/10mg Oint.
Posted April 6, 2004:
British Columbia
April 2004 Formulary Electronic Version
Posted April 6, 2004:
Saskatchewan
April 2004 Formulary Electronic Version
Posted April 2, 2004:
Alberta
Additions effective April 1, 2004
Highlights
New Product Added: Apo-Levocarb CR, Coversyl, Keppra (Special Authorization),
Mavik, Risperdal M-Tab, Xatral (Special Authorization), Apo-Ipravent Sterules
(Special Authorization), Apo-Amiodarone, Apo-Calcitonin, Fluconazole Omega,
Gen-Gabapentin, Novo-Carvedilol, Novo-Clavamoxin, Ratio-Mometasone, Ratio-Simvastatin,
Rhoxal-Simvastatin, Testosterone Cypionate; Interchangeable Products Added: Gen-Citalopram,
Novo-Fosinopril; Products Not Added: Alphagan P, Trileptal; Changes to Special Authorization Criteria:
Aricept, Exelon, Reminyl, Pegetron; Discontinued Special Authorization: Abelcet Lipid Com plex,
Ergamisol, Linmegestrol, Megace; Discontinued Products: Alti-Diltiazem, Atarax, Betaderm,
Betaderm Mild, Betaderm Regular, Chronovera, Cogentin, Cortoderm Mild, Cortoderm Regular,
Cortrosyn, Deproic, Diovan, Desquam-X, Erythromycin Lactobionate, Fluoderm Mild,
Fluoderm Regular, Fluvicin U/F, Garamycin, Gemfibrozil, Hyderm, Idarac, Largactil,
Midazolam, Morphine Sulfate, MS Contin, Netromycin, Novo-Desipramine, Novo-Methacin,
Nozinan, Nyaderm, Orudis, Pentacarinat,Peptol, PMS-Fluconazole, Proloprim, Promazine Hydrochloride,
Ratio-Captopril, Ratio-Desipramine Hydrochloride, Ratio-Haloperidol, Ratio-Naproxen,
Ratio-Orciprenaline, Rhodis, Rhotrimine, Rhovail, Santyl, Stemetil, Synflex, Taro-Carbamazepine CR,
Taro-Sone, Trazolrel, Triaderm Mild, Triaderm Regular, Vanceril, Vitamin B12, Vivelle, Vosol.
Posted April 2, 2004:
Saskatchewan
Formulary Bulletin 98 effective April 1, 2004
Highlights
New Full Benefit Listings: Ascensia Microfill Test Strip, Serc 24mg Tab,
Dom-Paroxetine, pms-Paroxetine 10mg Tab; New Interchangeable Products effective
April 1, 2004: pms-Mometasone, CO Pravastatin, Movo-Lamotrigine, Novo-Paroxetine,
Testosterone Cypionate, Methylprednisolone Acetate, ratio-Metformin,
ratio-Lamotrigine, ratio-Meloxicam, Novo-Clavamoxin, A;o-Ofloxacin;
New Interchangeable Products effective March , 2004: Apo-Citlopram, CO Citalopram,
Gen-Citalopram, pms-Citalopram, Rhoxal-Citalopram, Apo-Levocarb, pms-Mirtazapine,
Apo-Ciproflox, CO-ciprofloxacin, Gen-Ciprofloxacin, rtio-Ciprofloxacin, Rhoxal-Ciprofloxacin,
pms-Ciprofloxacin, Novo-Ciprofloxacin; Products Under Review: Gen-Clozapine,
Apo-Clozapine, Apo-Cyclosporine, Rhoxal-Cyclosporine, Apo-omeprazole, S
ab-Prochlorperazine, AlphagainP, Spiriva, Pegasys; Not Recommended: Preterax,
Proctofoam-HC, Ketek, Remeron, Preg Vit.
Posted April 2, 2004:
Newfoundland
Prescription Drug Benefit List March 26, 2004
Highlights
See Lists for details.
Posted April 2, 2004:
Manitoba
Prescription Drug Benefit List April 2004 and Interchangeability Formulary February 2004
Highlights
See Lists for details.
Posted March 30, 2004:
NovaScotia
March 2004 Bulletin effective April 1, 2004
Highlights
New Exception Status Products: Fludara 10mg Tab, Keppra 250, 500, 750mg Tabs,
Pegasys 180mcg/0.5ml Syr Inj and 180mcg/vial Inj, Thyrogen 0.9mg/mL Inj, Trileptal 150,
300, 600mg Tabs; New Diabetic Products Added: Ascensia Microfil Test Strips 50 and 100;
Benefit Status Change from Full Benefit to Exception Status: DDAVP 100mcg/mL Rhinyle Drops,
Apo-Desmopressin 10mcg/dose Nasal Sp, DDAVP 10mcg/dose Nasal Sp, DDAVP 0.1, 0.2mg Tabs;
Criteria Modification: Olanzapine; Not Insured: Pennsaid 1.5% Top Sol
Posted March 26, 2004:
NewBrunswick
Volume 45, Update No. 5 March 26, 2004
Highlights
Additions: ratio-Amcinonide 0.1% Top Crm, Cipro, pms-Ciprofloxacin, Apo-Ciproflox, Co-Ciprofloxacin, Gen-Ciprofloxacin, ratio-Ciprofloxacin, Rhoxal-Ciprofloxacin 250,500,750mg Tabs,
Celexa, Apo-Citalopram, Co-Citalopram, Gen-Citalopram, pms-Citalopram, Rhoxal-Citalopram 20, 40mg Tabs, Diflucan Inj, Fluconazole Inj 2mg/mL IV, Sofracort Ear/Eye Drops, Sab-Opticort 5mg Drops,
Rhoxal-Glyburide 2.5, 5mg Tabs, Novo-Lamotrigine 25, 100, 150mg Tabs, Rhoxal-Lovastatin 20, 40mg Tabs, Mobicox, ratio-Meloxicam, Apo-Meloxicam 7.5, 15mg Tabs, Apo-Metronidazole 500mg Cap, Remeron,
pms-Mirtazapine 30mg Tab, Ocuflox, Apo-Ofloxacin .3% Oph Liq, ratio-Paroxetine, Novo-Paroxetine 10, 20, 30mg Tabs, Co-Pravastatin 10, 20, 40mg Tabs, Co-Ranitidine 150, 300mg Tabs, ratio-Simvastatin 10, 20, 40, 80mg Tabs,
Apo-Tryptophan 50, 1000mg Tabs, Apo-Tryptophan 500mg Cap
Posted March 16, 2004:
Ontario
Formulary Version 38, Update C, effective April 6, 2004 effective January 1, 2004
Highlights
Product Additions: Single Source Full Coverage: Accuretic 20mg & 25mg Tab
Single Source Limited Use Coverage:Arixtra 2.5mg Inj-0.5mL Pk, Elidel 1% Cream, Ezetrol 10mg Tab,
Fludara 10mg Tab, Lumigan 0.03% Oph Sol-2.5mL Pk, Protopic Ointment 0.03% and 0.1%,
Singulair 4mg Chew Tab, Unidet 2mg and 4 mg ER Caps, Urso DS 500mg Tab.
Multi-Source Full Coverage: Amcort, Apo-Amiodarone, Apo-Cimetidine, Apo-Hydroxyurea
Apo-Paroxetine, Apo-Pimozide, Apo-Verap SR, Co-Pravastatin, Co-Simvastatin, Co-Citalopram,
Gen-Paroxetine, Ketoderm, Novo-Clavamoxin 875, Novo-Fosinopril, Novo-Paroxetine, Novo-Sertraline,
PMS-Amoxicillin, PMS-Meloxicam, PMS-Paroxetine, PMS-Pravastatin, PMS-Sertraline, Ratio-Amcinonide,
Ratio-Ketorolac, Ratio-Meloxicam, Ratio-Paroxetine, Ratio-Sertraline, Ratio-Simvastatin,
Multi-Source Limited Use Coverage:Apo-Carvedilol, Gen-Etidronate, Gen-Gabapentin,
Novo-Carvedilol, Novo-Lamotrigine, Novo-Ofloxacin, PMS-Carvedilol, PMS-Lamotrigine.
For more details, click here to view update C of Formulary version 38.
Posted March 12, 2004:
Newfoundland
Special Authorization Criteria - February 2004
Highlights
New Special Authorization Criteria: see document.
Posted March 10, 2004:
Saskatchewan
New Formulary Published - effective March 2004
Posted March 8, 2004:
Manitoba
Bulletin # 42 - effective April 1, 2004
Highlights
Additions: Apo-Amiodarone 200mg Tab, Apo-Carvedilol 3.125, 6.25, 12.5, 25mg tabs,
Apo-Hydroxyurea 500mg Cap, Apo-Naproxen EC 250, 375, 500mg ECTab, Apo-Paroxetine, 10,20,30mg Tab,
Apo-Varap SR 120, 180, 240mg SR Tab, Co Simvastatin 5,10,20,40,80mg Tab,
Gen-Paroxetine 10,20,30mg Tab, Novo-Carvedilol 3.125, 6.25,12.5, 25mg Tab,
pms-Lamotrigine 25, 200, 150mg Tab, pms-Paroxetine 10,20,30mg Tab,
pms-Pravastatin 10, 20, 30mg Tab, pms-salbutamol 0.4 mg/ml OL,
ratio-Amcinonide 0.1% TopCrm, ratio-Ketorolac 0.5% OphSol, ratio-Paroxetine 10,20,30mg Tab,
Rhoxal-bisoprolol 5, 10mg Tab, Rhoxal-glyburide 2.5, 5mg Tab, Rhoxal-metoprolol 5, 10mg Tab,
Rhoxal-pravastatin 10, 20, 40mg Tab, Sodium Aurothiomalate BP 10, 25, 50mg/ml Inj, Urso DS 500mg Tab;
Special Authorization Amendments and Additions: Cipro HC 2mg/10mg /mL, Gen-Etidronate 200mg Tab,
Novo-Ofloxacin 200, 300, 400mg Tab, Apo-Calcitonin 200IU Nas Spy, Prolastin, 1g Inj;
New Interchangeable Categories: see bulletin for list;
Product Deletions: see bulletin for list;
Interchangeable Product Price Changes: see bulletin for list;
Discontinued Products: Apo-Nefazodone, Gen-Nefazodone, Lin-Nefazodone,
Novo-Nefazodone-5HT2, pms-Nefazodone, Serzone-5HT2, Adrucil, Apo-Ibuprofen,
Aristocort, Atropine, Celestoderm V/2, Celestroderm V, Cipro 100, Clonapam,
Cortate, Edecrin, Ludiomil, Motrin, MS Contin, Novolin ge Lente, Novolin ge Ultralente,
Novo-Profen, Orudis SR, Pentasa, pms-Fluconazole, Procyclid, Propanthel, Rovamycine,
Surmontil, Vanceril, Vivelle, Voltaren, Wellferon
March 5, 2004:
NovaScotia
Pharmacare March 2004 Bulletin effective March 1, 2004
Highlights
Interchangeable products added: ratio-Amcinonide, Mobicox, ratio-Meloxicam; Notification
of Seniors' Pharmacare Program changes effective April 1, 2004 (see bulleting for details).
Posted February 26, 2004:
NovaScotia
PharmaCare February 2004 Bulletin effective February 1, 2004
Highlights
Clarification: Diovan 80 and 160mg Caps have been discontinued and replaced with the Tab form;
New Exception Status Products Added: Renagel 400 and 800mg Tab;
New Interchangeable Products and New MAC Categories: see Bulletin for details.
Posted February 16, 2004:
Newfoundland
Newfoundland and Labrador Drug Benefit List effective February 2004
Highlights
Please see listing for details.
Posted February 9, 2004:
NewBrunswick
Bulletin # 585 Benefit Changes. Interchangeable Products update volume 45 Update #4
Highlights
Effective January 30, 2004: New Full Benefit: Apo-Metoprolol 25mg Tab, Vagifem 25mcg Tab, Avelox 400mg Tab;
New Special Authorization: Gen-Clozapine 25,100 mg Tab (also New Interchangeable), DDAVP 0.1, 0.2 mg Tab,
Avelox 400mg Tab, Renagel 400, 800 mg Tab, Marinol 2.5, 5, 10mg Cap;
Modifications to Current Special Authorization: Foradil 12mcg Inh Cap, Oxeze 12mcg Inh Turbuhaler, Serevent 25mcg MDI and 50mcg Diskus;
Products Reviewed and Not Listed:Xatral 10mg Tab, Hectorol 2.5mcg Cap, Fucithalmic 1% viscous Oph Drops, Zaditor 0.25% Oph Sol.
Posted February 5, 2004:
Saskatchewan
ulletin # 97 effective February 2004
Highlights
Effective February 1, 2004: New Full Benefit: Ezetrol 10mg Tab, Keppra 250, 500, 750mg Tab, Dapsone 100mg Tab, Accuretic 20mg/25mg Tab,
Risperdal-M 0.5, 1, 2mg Orally Disintegrating Tab, Coversyl 8mg Tab;
New Exception Drug Status: Elidel 1% Top Crm, Trileptal 150, 300, 600 mg tab, 60mg/ml O/Susp, Bextra 20mg Tab,
Venofer 20mg/ml Inj, 3TC 300mg Tab, Zyprexa Zydis 15mg Orally Disintegrating Tab, Metadol
(restricted to registered Palliative Care) 1, 5, 10, 25mg Tab, 1mg/ml O/Susp;
New Interchangeable Listings: see bulletin for details;
Modifications to Current Exception Drug Status: Cipro 250, 500, 750mg Tab, 100mg/ml O/Susp,
Levaquin 250, 500 mg Tab, Avelox 400mg Tab, Tequin 400mg Tab, Prevacid 15, 30mg delayed release Cap,
Losec 20mg delayed release Tab, Pariet 10mg Tab, Enbrel 25mg/vial Inj Pwr, Protopic 0.03, 0.1% Top Oint,
Zyprexa 2.5, 5, 7.5, 10, 15mg Tab, Zyprexa Zydis 5, 10, 15mg Orally Disintegrating Tab;
Products Reviewed and Not Recommended: Cipro XL 500mg Tab, Concerta 18, 36, 54mg Tab, Spiriva 18mcg Inh Cap,
Pennsaid 1.5% Top Sol, Paxil 10mg Tab, Apo-Paroxetine 10mg Tab, Gen-Paroxetine 10mg Tab, PMS-Paroxetine 10mg Tab
Products Under Review: Gen-Clozapine 25, 100mg Tab, Apo-Cyclosporine 100mg/ml Liquid, Rhoxal-Cyclosporine 100mg Cap,
Ketek 400mg Tab, Apo-Omeprazole 20mg Cap, Pegasys Injection 180mcg/0.5ml syringe and 180mcg/1ml vial
February 4, 2004:
BritishColumbia
Pharmacare Newsletter dated January 29, 2004
Highlights
New Products Added to Plans B, C, F: Gen-Citalopram 20mg and 40mg Tab, Crestor 10mg, 20mg, and 40mg Tab;
Non Benefits: Ketek 400mg Tab, Amaryl 1mg, 2mg and 4mg Tab;
New LCA Categories: Citalopram Hydrobromide 20mg, 40mg Tab, Estradiol Patch 50mcg, 75mcg and 100mcg (requires Special Authority);
Drugs Under Review: Xatral, Axert, Kineret, Serc, Botox, Metadol, Concerta, Remeron RD, Evra (CommonDrugReview), Trileptal,
Alphagan, Combigan (CommonDrugReview), Cipro XL, Plavis, DDAVP, Aricept, Enbrel, Ezetrol, Zrixtra, Reminyl, Cytovene, Iressa (CommonDrugReview),
Avonex, Avapro, Xalacom, Keppra, Cozaar, Pegasys, Coversyl, Preterax, Elidel, Actos, Actonel, Risperdal M-TAB, Exelon, Vioxx, Avandia, Protopic,
Androderm, Spiriva, Mavik, Urso, Diaplex
Posted February 3, 2004:
Alberta
Alberta Health & Wellness Additions effective February 1, 2004
Highlights
New Drug Products: Novo-Fosinopril 10mg and 20mg Tab, Gen-Citalopram 20mg and 40mg Tab,
Risperdal M-TAB 0.5mg, 1mg and 2mg Disintigrating Tab; Change in Benefit Status from Special to full: Actos 15mg, 30mg and 45mg Tab
Posted January 23, 2004:
Quebec
Quebec Formulary Update January 28,2004
Highlights
Additions: Keppra 250mg, 500mg, 750mg;
Exception Status Modifcations: Advair Diskus 50mcg-100mcg, 50mcg-250mcg, 50mcg-500mcg; Advair Oral 25mcg-125mcg, 25mcg-250mcg;
Symbicort Turbuhaler 6-mcg-100mcg, 6mcg-200mcg; Spiriva 18mcg Pwd/Inh.
Posted January 21, 2004:
Nova Scotia
January Bulletin, January 2004
Highlights
New Maximum Allowable Cost List: effective February 1, 2004;
Categories removed from MAC List: Dobutamine 12.5mg/mL Inj, Nefazodone 100, 150, and 200mg Tab,
Tobramycin 10mg/mL Inj, Vancomycin 500mg and 1g/vial Inj; Discontinued Products: Amicar 250mg/mL Inj, Aristocort 4mg Tab, Atropine 1% Oph Sol,
Cytotec 100mcg Tab, Diovan 80 and 160mg Cap, MS Contin 30, 60, 100, and 200mg Supp, Surmontil 100mg Tab, Vanceril 50mcg/dose Oral Inh,
Vivelle 27.5, 50, 75, and 100mcg/day Patch, Voltaren 25mg Tab
Posted January 13, 2004:
British Columbia
New Formulary Version effective January 1, 2004
Posted January 6, 2004:
NewBrunswick
Bulletin 584 dated December 23, 2003
Highlights
New Interchangeble Products Added: Novo-Clavamoxin 875mg/126mg Orl, Phoxal-Atenolol 50mg, 100mg Orl,
Miacalcin and Apo-Calcitonim 200IU Nas, Tegretol Chew and pms-Carbamazepine Chewtabs 100mg, 200mg Orl,
Novo-Carvedilol 3.125mg, 6.25mg, 12.5mg, 25mg Orl, Didronel and Gen-Etidronate 200mg Orl,
Monorpil and Novo-Fosinopril 10mg, 20mg Orl, Gen-Gabapentin 100mg, 300mg, 400mg Orl, Apo-Hydroxyurea 500mg Orl,
Novo-Metformin 500mg Orl, Rhoxal-Metoprolol type "L" 50mg, 100mg Orl, Elocom and pms-Mometasone 0.1% Top,
Apo-Naproxen EC 250mg, 375mg, 500mg Orl, Paxil and Apo-Paroxetine and Apo-Paroxetine and Gen-Paroxetine
and pms-Paroxetine 10mg, 20mg, 30mg Orl, Rhoxal-Pravastatin 10mg, 20mg, 40mg Orl, Novo-Selegiline 5mg Orl
|
|
|
|
|
|
|
|
